Riskpilot← Back to searchSign inGet full accessiFunktion Fysioterapi Corpus AB
ABActiveOrg 5569838161Bökersgatan 7Physiotherapy activities · NACE 8695Est. 20141 employees
Revenue 2024
SEK 1,5M
+2% vs 2023
EBITDA margin
28.6%
+5% vs 2023
Equity ratio
33.5%
Financial strength
Net profit 2024
SEK 328K
+10% vs 2023
| Revenue | SEK 1,5M | +2% |
| EBITDA | SEK 438K | +5% |
| Net profit | SEK 328K | +10% |
| Total assets | SEK 2,4M | +18% |
| Equity | SEK 802K | +4% |
| Employees | 1 | — |
Legal name
iFunktion Fysioterapi Corpus AB
Org number
5569838161
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
23 september 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva fysioterapi, konsultationer och kursverksamhet inom fysioterapi, försäljning av träningshjälpmedel samt därmed förenlig verksamhet.
Address
Bökersgatan 7
Email
s.e.schultz@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 435 | 1 458 | 1 355 | 1 509 | 1 534 |
| Staff expenses | — | — | −641 | −674 | −682 |
| EBITDA | 478 | 410 | 303 | 417 | 438 |
| Depreciation & amort. | −0 | −4 | −12 | −12 | −12 |
| EBIT | 478 | 406 | 291 | 404 | 426 |
| Net financials | — | — | 1 | 24 | 23 |
| Profit before tax | 478 | 405 | 250 | 378 | 417 |
| Tax | −104 | −85 | −51 | −81 | −89 |
| Net profit | 374 | 320 | 199 | 297 | 328 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 122 | 1 454 | 1 660 | 2 030 | 2 390 |
| Equity | 858 | 878 | 777 | 774 | 802 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 156 | 467 | 733 | 1 056 | 1 356 |
| Total debt | 156 | 467 | 733 | 1 056 | 1 356 |
EBITDA margin
28.6%
This company
15.8%
Market median
+81% vs market
20202024
Equity ratio
33.5%
This company
38.2%
Market median
+12% vs market
20202024
Return on equity
40.9%
This company
18.4%
Market median
+122% vs market
20202024
Net profit margin
21.4%
This company
8.1%
Market median
+164% vs market
20202024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20202024
Debt / equity
1.98×
This company
0.62×
Market median
-219% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of iFunktion Fysioterapi Corpus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ernst Johan Olof Burell | Deputy Board Member | 0 companies |
| Susanne Elisabeth Schultz | Board of Directors | 0 companies |